How to Source Sitagliptin + Metformin tablets for Pharmaceutical Formulation
Sitagliptin + Metformin tablets (Tablets, 50/500 mg, 50/850 mg, 50/1000 mg) is classified under Diabetes. It is therapeutically aligned with reference brands such as Janumet (US & EU). This guide highlights key sourcing factors buyers should consider when procuring high-quality Sitagliptin + Metformin tablets for formulation, R&D, or bulk manufacturing.
Product Overview:
Sitagliptin + Metformin combines DPP-4 inhibition with insulin sensitization. Sitagliptin boosts incretin hormones, enhancing insulin release and reducing glucagon. Metformin decreases hepatic glucose production and improves peripheral glucose uptake. This dual mechanism provides superior glycemic control, lowers HbA1c, and minimizes hypoglycemia risk—ideal for managing Type 2 diabetes effectively.
1. Regulatory Compliance & Documentation
Ensure suppliers provide:
- ✔ Valid DMF (Drug Master File)
- ✔ COA (Certificate of Analysis) for each batch
- ✔ GMP, ISO, or ICH Q7 compliance certificates
2. Purity, Grade & Specification Matching
Sitagliptin + Metformin tablets must meet exact grade and purity for your dosage form:
- ✔ USP / EP / JP grade verification
- ✔ Particle size distribution check
- ✔ Residual solvent and heavy metal limits
3. Supplier Reliability & Audit History
- ✔ Positive past audit reports
- ✔ Pharma client references
- ✔ Years of proven API manufacturing experience
4. Commercial Terms: Pricing, MOQ & Flexibility
- ✔ Transparent pricing
- ✔ Pilot batch MOQ flexibility
- ✔ Volume-based discounts
5. Lead Time, Inventory & Logistics
Typical lead time for Sitagliptin + Metformin tablets is 4–6 weeks.
- ✔ Emergency dispatch options
- ✔ Regional warehousing
- ✔ Special storage if needed
6. Formulation Support
- ✔ Technical datasheets
- ✔ Sample availability
- ✔ Stability study support
Conclusion
Sourcing Sitagliptin + Metformin tablets is more than procurement—it’s a strategic partnership. With its tablets form and 50/500 mg, 50/850 mg, 50/1000 mg specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.
Next Step: Get expert assistance in sourcing Sitagliptin + Metformin tablets.
Frequently Asked Questions For Sourcing of Sitagliptin + Metformin tablets
What is the typical lead time for Sitagliptin + Metformin tablets?
Lead times range from 4–6 weeks depending on supplier and region.
Is Sitagliptin + Metformin tablets available in multiple grades?
Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.
Does Sitagliptin + Metformin tablets require special storage?
It should be stored in a cool, dry place away from direct sunlight.
Is a Drug Master File (DMF) available for Sitagliptin + Metformin tablets?
Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.
Can I request samples or a pilot batch of Sitagliptin + Metformin tablets?
Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.
What compliance certificates are available for Sitagliptin + Metformin tablets?
Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.
Is Sitagliptin + Metformin tablets suitable for regulated markets like US/EU?
Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.
Can Sitagliptin + Metformin tablets be used in fixed-dose combinations?
Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.
Advertise on PharmaTradZ
Reach verified pharma buyers, suppliers & decision makers worldwide.
Explore Pharma Investment Opportunities
Connect with partners, startups & ventures driving the future of pharma.